BioScrip Cash Flow - Quarterly (NASDAQ:BIOS)

Add to My Stocks
$3.02 $0.03 (1%) BIOS stock closing price Feb 23, 2018 (Closing)

The BioScrip cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows BioScrip profits, the balance sheet shows BioScrip debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. BioScrip saw a cash impact of $- from the buyback of BIOS shares. The cash flow statement helps in the BioScrip stock analysis by providing more information for evaluating changes in assets, liabilities and equities. BIOS decrease in investments stood at a value of $-9.99M for the latest quarter 2017 Q3.

View and download details of BioScrip cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
-61.14M-48.62M-19.42M-41.5M-29.03M-17.77M-9.53M-299.7M-281.26M
Depreciation Depletion Amortization Cash-Flow24.94M16.65M8.3M25.59M15.96M10.77M5.54M26.18M271.5M
Net Increase (Decrease) in Assets Liabilities12.17M10.55M-1.05M-11.43M-14.57M-9.88M-1.5M-21.28M-39.75M
Cash From (used in) Discontinued Operations-5.5M---0.42M-6.22M-6.22M-6.22M-6.17M-1.11M
Other Adjustments Net18.62M16.38M1.14M-14.99M-4.66M1.5M-236.24M-16.79M
Net Cash from (used by) Operating Activities
-10.89M-5.03M-11.03M-42.76M-38.53M-21.58M-10.96M-64.74M-67.41M
Increase (Decrease) in Prop Plant And Equipment-5.04M-4.29M-1.68M-5.46M-3.86M-4.33M-1.32M-11.54M-9.35M
Acquisition Disposition of Subsidiaires----67.51M-67.51M----
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-4.95M-5.05M-5.13M----24.56M22.37M
Net Cash from (used by) Investment Activities
-9.99M-9.34M-6.81M-72.98M-71.38M-4.33M-1.32M13.02M13.01M
Issuance (Purchase) of Equity Shares-20.77M5.05M83.06M-83.26M-59.58M59.69M
Issuance (Repayment) of Debt Securities79.94M80.33M19.68M-13.62M-9.93M-6.4M-3.18M-0.39M-0.31M
Increase (Decrease) in Bank & Other Borrowings-55.3M-55.3M-0.43M40.3M24M-15M8M10M25M
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities19.69M-0.46M-0.05M-83.11M-0.09M-0.05M-2.63M-1.27M
Net Cash from (used by) Financing Activities
44.33M45.34M24.24M109.74M97.17M61.77M4.75M66.55M83.09M
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
23.44M30.96M6.4M-6M-12.74M35.84M-7.52M14.83M28.7M
Cash & Equivalents at Beginning of Year15.57M-1M62.1M-----
Cash & Equivalents at Year End33.01M40.53M15.96M9.56M2.83M51.42M8.05M15.57M29.44M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

BioScrip stock comparison chart provides an easy way to compare the stock price with peers along with details of BioScrip stock price history.
The statement of cash flows can be categorized into the following main sections:

  • BioScrip saw a negative change in Net Change in Cash and Cash Equivalents of $23.44M till 2017 Q3. Apart from the BioScrip stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • BioScrip decreased its cash from operating activities to $-10.89M till 2017 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-9.99M for BIOS till last quarter 2017 Q3 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $44.33M for BioScrip.

Key Financial Ratios For BioScrip Cash Flow